Serum sFRP2 was positively associated with circulating insulin, homeostasis model assessment of β cell secretory capacity (HOMA-β) and insulin resistance (HOMAIR), body mass index (BMI) and triglycerides (TG), and was increased in patients with abnormal glucose tolerance (AGT) (28). Here, SFRP2 is linked to Insulin resistance.